Fundraising Fox3Bar Biologics
Columbus, US · Founded 2013 · Ohio corporation · 2 known investors
Find your way into 3Bar Biologics
Sign up to see every warm intro you have to 3Bar Biologics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 3Bar Biologics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
DB
RM
Richard MaksimoskiBoard director
RA
Rashmi AgnihotriBoard director
Investors · 2
Rev1 VenturesreportedColumbusvia David Bergeron · board
How we know: board seat on SEC Form D · funding news · Not right? Tell us
S2G InvestmentsreportedChicago · $1M – $5M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$2.4M disclosed across 2 rounds · 2016–2020
▶$780KraisedNov 2020 · 11 investors · Other TechnologyRule 506(b)
▶$780KraisedNov 2020 · 11 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Richard MaksimoskiDirector
- Bruce CaldwellExecutive Officer, Director
- David BergeronDirector
- Rashmi AgnihotriDirector
- Offering amount
- $1M
- Amount sold
- $780K
- First sale
- Nov 2020
- Incorporated
- Corporation, Ohio
- Federal exemptions
- 06b
▶$1.6MraisedApr 2017 · 12 investors · Other TechnologyRule 506(b)
▶$1.6MraisedApr 2017 · 12 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- David BergeronDirector
- Bruce CaldwellExecutive Officer, Director
- Richard MaksimoskiDirector
- Rashmi AgnihotriDirector
- Offering amount
- $2M
- Amount sold
- $1.6M
- Minimum investment
- $10K
- First sale
- Dec 2016
- Incorporated
- Corporation, Ohio, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
Third Arc BioThird Arc Bio develops breakthrough treatments in oncology and immunology through advanced biologics engineering. The company is led by a team with a track record of 35+ drug approvals.
3T Biosciences3T Biosciences develops TCR-based immunotherapies for cancer using a proprietary platform that combines machine-learning algorithms with immunological research to identify and validate T cell receptor targets. The company creates therapeutic treatments targeting cancer and other difficult-to-treat diseases.
TripleBar Bio, Inc.Triplebar builds an AI platform for Genomic Design Automation (GDA), using microfluidics to generate large-scale biological datasets with matched genotype and phenotype at lower cost and faster than liquid handling robotics. It applies machine learning to biological data to support biotechnology research and product engineering.
3PBIOVIAN3PBIOVIAN is a global Contract Development and Manufacturing Organization (CDMO) providing end-to-end biopharmaceutical manufacturing services for biotech and pharma companies. The company offers microbial and mammalian protein expression, viral vector production, cell therapy, plasmid DNA production, and fill & finish services across multiple locations in Spain, Finland, and the United States.
32 Bio SciencesA biotech company focused on microbiome and metabolomics research for gastrointestinal health applications, with leadership and scientific advisory rooted in academic medicine and regulatory expertise.
Companies working in the same space as 3Bar Biologics.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Department of Agriculture (USDA) | Phase II | 2022 | $650K |
| Department of Agriculture (USDA) | Phase I | 2021 | $100K |
| Department of Agriculture (USDA) | Phase II | 2017 | $600K |
| Department of Agriculture (USDA) | Phase I | 2016 | $100K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- Who are 3Bar Biologics's investors?
- 3Bar Biologics's investors include Rev1 Ventures, S2G Investments.
- How much funding has 3Bar Biologics raised?
- 3Bar Biologics has disclosed $2.4M raised across 2 rounds.
- Where is 3Bar Biologics headquartered?
- 3Bar Biologics is headquartered in Columbus, US.